Korro Bio (KRRO) Earnings Date & Reports

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KRRO is expected to report earnings to rise 17.76% to -125 cents per share on November 18

Q3'26

Est.

$-1.26

Q2'26

Beat

by $0.24

Q1'26

Beat

by $1.68

Q4'25

Missed

by $2.90

Q3'25

Beat

by $0.35

The last earnings report on August 06 showed earnings per share of -107 cents, beating the estimate of -130 cents. With 89.86K shares outstanding, the current market capitalization sits at 144.75M.

View a ticker or compare two or three

KRRO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for KRRO